CAS 1639208-54-0: Valbenazine tosylate

Valbenazine tosylate, the tosylate salt of valbenazine, is a vesicular monoamine transporter 2 (VMAT2) inhibitor with a Ki value of 150 nM while displaying no

Valbenazine tosylate is a drug that acts as an inhibitor. It is used in the treatment of Tourette syndrome, a disorder characterized by involuntary movements, vocalizations, or thoughts called tics. Valbenazine tosylate inhibits the enzyme monoamine oxidase-A (MAO-A), which affects dopamine levels in the brain. This drug has been shown to be effective for treating Tourette syndrome in patients with hepatic impairment and those who are obese. The side effects of this drug include nausea, vomiting, headache, and dizziness. Valbenazine tosylate may also cause dyskinesia, which is characterized by involuntary movements of the face and extremities.